Rola Fayad Shares Key Clinical Updates on Anemia in CKD from KDIGO 2026
Rola Fayad, Nephrologist at HHUMC, shared on LinkedIn:
‘‘KDIGO 2026 Anemia in CKD: Key Clinical Updates!
The new KDIGO 2026 Guideline for Anemia in CKD offers clearer definitions, more precise thresholds, and a more patient‑centered approach to anemia management.
As nephrologists, these updates help us deliver safer and more individualized care.
Definition and Screening:
– Anemia: Hb <12 g/dL (women), <13 g/dL (men).
– Screening:
• G3: yearly
• G4: twice yearly
• G5/dialysis: every 3 months
Initial tests: CBC, reticulocytes, ferritin, TSAT.
Updated Iron Concepts:
– Systemic iron deficiency: ferritin <100 ng/mL (ND) or <200 ng/mL (HD), TSAT <20%.
– Iron‑restricted erythropoiesis: ferritin >100–200 ng/mL with TSAT <20%.
When to Start Iron Therapy:
– Hemodialysis:
• Start IV iron if ferritin ≤500 ng/mL and TSAT ≤30%.
• Withhold if ferritin >700 ng/mL or TSAT ≥40%.
– Non‑dialysis CKD:
• Ferritin <100 and TSAT <40%, or
• Ferritin 100–300 and TSAT <25%
– Oral or IV based on tolerance and response.
– Hold iron during active infection.
ESA Therapy:
– Dialysis: start when Hb ≤9–10 g/dL.
– Non‑dialysis: consider at Hb 8.5–10 g/dL based on symptoms.
– Do not maintain Hb ≥11.5 g/dL.
– Monitor Hb every 2–4 weeks.
– Suspend ESA during stroke or thrombosis; use caution in active malignancy.
HIF‑PHIs:
– Option when ESA intolerance or hypo-responsiveness.
– Avoid in active malignancy, recent CV/thrombotic events, Pregnancy, Pulmonary hypertension, Proliferative retinal disease.
– Stop after 3–4 months if no response.
Transfusions:
– Reserved for acute or symptomatic or life‑threatening anemia.
-Avoid when possible in transplant candidates.
What I appreciate most about these guidelines is that they remind us of something essential: Anemia Management in CKD is not just about numbers it’s about people.
It’s about reducing fatigue, improving cognition, protecting the heart, and restoring dignity and quality of life.
These recommendations help us deliver care that is safer, more precise, and more compassionate.”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 07:18Raising Awareness of Inherited Bleeding Disorders in Women and Girls – World Federation of Hemophilia
-
Nov 21, 2026, 07:10Emmanuel J Favaloro: Latest Publication Posted Online at Seminars in Thrombosis and Hemostasis
-
Nov 21, 2026, 06:52Novel ADAMTS13 Fusion Construct Targets Dual Mechanisms in Immune-Mediated TTP – JTH
-
Nov 21, 2026, 06:38Michael Lichtenberg: Long-Term Results of Venovo Venous Stenting From the Arnsberg Venous Registry
-
Nov 21, 2026, 06:24Platelets Journal: Glycocalicin Accumulation Within Thrombi Reveals Species-Specific Mechanisms
-
Nov 21, 2026, 03:45Aref Ghanaatpisheh: The Role of Systemic Inflammation in Preoperative Deep Vein Thrombosis Risk Assessment
-
Nov 21, 2026, 03:43Dimitrios Hatzichristou: Advancing Standardization and Quality Control in Platelet-Rich Plasma Therapy
-
Nov 21, 2026, 03:15Amirabbas Sheykhalo: Silent Mesenteric Ischemia in Portomesenteric Thrombosis
-
Nov 21, 2026, 02:51Ivone Su: Raising Awareness of Venous Thromboembolism